This article considers force use in clinical settings after a triggering event—a behavioral or medical crisis—and considers how it should be implemented.
AMA J Ethics. 2021;23(4):E326-334. doi:
10.1001/amajethics.2021.326.
New guidelines and the continuous modification of current policies will be needed in order to establish and maintain an appropriate professional relationship between physicians and pharmaceutical companies.